Standard Biotools (LAB) Non-Current Assets (2010 - 2026)

Standard Biotools (LAB) has 17 years of Non-Current Assets data on file, last reported at $117.7 million in Q1 2026.

• Quarterly Non-Current Assets fell 50.05% year-over-year to $117.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $471.4 million (down 48.89% YoY) and the FY2025 annual result came in at $46.0 million, down 6.76% from the prior year.
• Non-Current Assets improved to $117.7 million in Q1 2026 per LAB's latest filing, from $46.0 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $235.6 million in Q1 2025 and bottomed at $46.0 million in Q4 2025.
• The 5-year median for Non-Current Assets is $172.8 million (2023), against an average of $144.7 million.
• The widest annual swing landed in 2024, when Non-Current Assets surged 35.24%; it then sank 77.73% in 2025.
• Tracing LAB's Non-Current Assets over 5 years: stood at $59.5 million in 2022, then retreated by 7.87% to $54.8 million in 2023, then slipped by 10.04% to $49.3 million in 2024, then decreased by 6.76% to $46.0 million in 2025, then soared by 155.75% to $117.7 million in 2026.
• Per Business Quant, the three latest LAB Non-Current Assets figures stand at $117.7 million (Q1 2026), $46.0 million (Q4 2025), and $67.2 million (Q3 2025).

Peer Comparison